Bioclavis Limited
Research and experimental development on biotechnology · Clydebank
ActiveUnited KingdomIncorporated 2017Private Limited Company
Financial position
Accounts to 2024-12-31 · GBP · company scope
Net assets
£1,075,408
Cash
£685,216
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
—
Equity
£1,075,408
Average employees
11
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2024-12-31GBP · company | 2023-12-31GBP · company | 2022-12-31GBP · unknown | 2021-09-30GBP · unknown | 2020-09-30GBP · unknown | 2019-09-30GBP · unknown | 2018-09-30GBP · unknown |
|---|---|---|---|---|---|---|---|
| Balance sheet | |||||||
| Net assets | £1,075,408 | £1,174,490 | £1,542,978 | £1,597,869 | £598,640 | — | — |
| Equity | £1,075,408 | £1,174,490 | £1,542,978 | £1,597,869 | £598,640 | £309,375 | £215,734 |
| Assets | |||||||
| Property, plant & equipment | £142,114 | £244,241 | £378,139 | £300,361 | £147,879 | £96,681 | £29,584 |
| Current assets | — | — | — | — | — | £502,632 | £242,839 |
| Cash at bank | £685,216 | £697,474 | £870,097 | £981,596 | £685,051 | £236,921 | £124,987 |
| Debtors | — | — | — | — | — | £265,711 | £117,852 |
| Liabilities | |||||||
| Net current assets | — | — | — | — | — | £212,694 | £186,150 |
| Assets less current liabilities | — | — | — | — | — | £309,375 | £215,734 |
| People | |||||||
| Average employees | 11 | 13 | 27 | 23 | 17 | 8 | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.